We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

AAP Implantate AG (AAQ1) NPV

Sell:€3.52 Buy:€3.68 Change: €0.12 (3.41%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:€3.52
Buy:€3.68
Change: €0.12 (3.41%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:€3.52
Buy:€3.68
Change: €0.12 (3.41%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

aap Implantate AG is a Germany-based provider of medical devices for human muscular and skeletal systems. The Company focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . It also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The Company operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.

Contact details

Address:
Lorenzweg 5
BERLIN
12099
Germany
Telephone:
+49 (30) 750190
Website:
https://www.aap.de/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
AAQ1
ISIN:
DE000A3H2101
Market cap:
€18.42 million
Shares in issue:
4.73 million
Sector:
Health Care Equipment
Exchange:
Frankfurt Stock Exchange
Country:
Germany
Currency:
Euro
Indices:
n/a

Key personnel

  • Nathalie Krebs
    Chairwoman of the Supervisory Board
  • Rubino Di Girolamo
    Chairman of the Management Board, Chief Executive Officer
  • Jacqueline Rijsdijk
    Deputy Chairman of the Supervisory Board
  • Marek Hahn
    Chief Financial Officer, Member of the Management Board
  • Agnieszka Mierzejewska
    Chief Operating Officer, Member of the Management Board

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.